United Services Automobile Association’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,196
Closed -$436K 885
2025
Q1
$436K Buy
+6,196
New +$652K 0.01% 614
2019
Q3
Sell
-11,046
Closed -$1.68M 1555
2019
Q2
$1.68M Sell
11,046
-169
-2% -$20.5K ﹤0.01% 1153
2019
Q1
$1.34M Buy
11,215
+24
+0.2% +$3.08K ﹤0.01% 1207
2018
Q4
$1.22M Buy
11,191
+1,320
+13% +$165K ﹤0.01% 1186
2018
Q3
$1.59M Buy
9,871
+417
+4% +$57K ﹤0.01% 1195
2018
Q2
$1.25M Hold
9,454
﹤0.01% 1272
2018
Q1
$700K Buy
+9,454
New +$630K ﹤0.01% 1557
2015
Q2
Sell
-16,990
Closed -$226K 1295
2015
Q1
$226K Sell
16,990
-26,040
-61% -$347K ﹤0.01% 1248
2014
Q4
$623K Hold
43,030
﹤0.01% 1160
2014
Q3
$908K Hold
43,030
﹤0.01% 1101
2014
Q2
$1.28M Hold
43,030
﹤0.01% 1037
2014
Q1
$1.03M Buy
43,030
+13,500
+46% +$344K ﹤0.01% 1078
2013
Q4
$602K Hold
29,530
﹤0.01% 1132
2013
Q3
$1.4M Buy
29,530
+4,900
+20% +$189K 0.01% 997
2013
Q2
$937K Buy
+24,630
New +$881K ﹤0.01% 1043

Other funds holding SRPT

United Services Automobile Association's SRPT Position: Q2 2025 in Review

United Services Automobile Association sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 6,196 shares — an estimated $436K sold.

United Services Automobile Association first reported a position in SRPT in Q2 2013 and held it in 15 quarters. The position peaked at $1.68M in Q2 2019. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • United Services Automobile Association reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • United Services Automobile Association sold 6,196 Sarepta Therapeutics shares in Q2 2025, an estimated $436K.
  • United Services Automobile Association first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 15 quarters.
  • United Services Automobile Association's Sarepta Therapeutics position peaked at $1.68M in Q2 2019.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on United Services Automobile Association's 13F filing for Q2 2025, filed 15 Aug 2025.